Cargando…

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults

This proof-of-concept study tested if prior BCG revaccination can qualitatively and quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca ChAdOx1nCoV-19 or COVISHIELD™, an efficacious and the most widely distributed vaccine in India. We compared COVISHIELD™ induced longitu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rakshit, Srabanti, Adiga, Vasista, Ahmed, Asma, Parthiban, Chaitra, Chetan Kumar, Nirutha, Dwarkanath, Pratibha, Shivalingaiah, Sudarshan, Rao, Srishti, D’Souza, George, Dias, Mary, Maguire, Thomas J. A., Doores, Katie J., Zoodsma, Martijn, Geckin, Busranur, Dasgupta, Prokar, Babji, Sudhir, van Meijgaarden, Krista E., Joosten, Simone A., Ottenhoff, Tom H. M., Li, Yang, Netea, Mihai G., Stuart, Kenneth D., De Rosa, Stephen C., McElrath, M. Juliana, Vyakarnam, Annapurna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577398/ https://www.ncbi.nlm.nih.gov/pubmed/36268023 http://dx.doi.org/10.3389/fimmu.2022.985938

Ejemplares similares

BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD(™) vaccine in SARS-CoV-2 seronegative young Indian adults
por: Rakshit, Srabanti, et al.
Publicado: (2022)

Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD(TM) and COVAXIN(®) induced immunity in COVID-19 exposed Indians
por: Rakshit, Srabanti, et al.
Publicado: (2023)

Differences in Immune Responses in Individuals of Indian and European Origin: Relevance for the COVID-19 Pandemic
por: Geckin, Büsra, et al.
Publicado: (2023)

BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways
por: Ahmed, Asma, et al.
Publicado: (2023)

Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10(+) Th17 CD4 T-cells differentiate latent from active tuberculosis
por: Rakshit, Srabanti, et al.
Publicado: (2017)

Innate immune mechanisms to oral pathogens in oral mucosa of HIV-infected individuals
por: Weinberg, Aaron, et al.
Publicado: (2020)

Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis
por: Pal, Virender Kumar, et al.
Publicado: (2021)

Covid-19 vaccine (covishield) heralding Moyamoya angiopathy()()()
por: Das, Shambaditya, et al.
Publicado: (2022)

Covishield vaccine induces robust immune responses in Bangladeshi adults
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD
Publicado: (2021)

Circulating HLA-DR(+)CD4(+) effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis
por: Ahmed, Asma, et al.
Publicado: (2018)

Adverse Events Following COVISHIELD Vaccination Among Adult Population in Bangladesh
por: Khalil, Md. Musab, et al.
Publicado: (2021)

Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
por: Chaurasia, Bipin, et al.
Publicado: (2022)

Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report
por: Basnet, Angela, et al.
Publicado: (2021)

Myoglobinuria-induced Acute Kidney Injury Secondary to Covishield(TM) Vaccination
por: Fatima, Rana, et al.
Publicado: (2022)

Covishield vaccination and pulmonary thromboembolism: A coincidence or a causal association?
por: Divas, Rijal, et al.
Publicado: (2023)

Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
por: Hickman, Oliver J., et al.
Publicado: (2016)

AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal
por: Sah, Ranjit, et al.
Publicado: (2021)

Harada-like syndrome post-Covishield vaccination: A rare adverse effect
por: Reddy, Yogya, et al.
Publicado: (2022)

To study the effect of ‘Covishield’ vaccination on pre-donation platelet counts of plateletpheresis donors
por: Tomar, Akshaya, et al.
Publicado: (2023)

Post-vaccination Symptoms of Covishield Vaccine among Frontline Workers of a Tertiary Care Center in Pathanamthitta District
por: Dev, Sahya S., et al.
Publicado: (2023)

Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression
por: Thomas, Rhema Elizabeth, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
por: Marfoh, Kissinger, et al.
Publicado: (2023)

Reverse Takotsubo Cardiomyopathy Following COVISHIELD Vaccination: A Rare Case of an Anaphylactic Reaction
por: Shah, Mandar M, et al.
Publicado: (2023)

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Effectiveness of Covishield vaccine in preventing Covid-19 – A test-negative case-control study
por: Pramod, Stuti, et al.
Publicado: (2022)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Mycobacterium tuberculosis Strains
por: Ramaiah, Arunachalam, et al.
Publicado: (2019)

Falsified COVISHIELD products in India and Uganda
Publicado: (2021)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in Nepal
por: Poudel, Kapil Madi, et al.
Publicado: (2022)

Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Adverse events associated with Covishield vaccination among healthcare workers in a tertiary hospital in South India
por: T Sathyapalan, Dipu, et al.
Publicado: (2022)

2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin )
por: Mitra, Debdeep, et al.
Publicado: (2023)

Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine
por: Sivaramakrishnan, Prakash, et al.
Publicado: (2022)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Impact of ChAdOx1 nCoV-19 (Covishield™) Vaccination: How Long Will It Persist?
por: Devi, Leimapokpam Sumitra, et al.
Publicado: (2022)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
por: Natung, Tanie, et al.
Publicado: (2023)

Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2
por: Hickman, Oliver J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_709bvt6bou0vqut6kuqq2v87i8